Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Alzheimer's Disease

Free Subscription 03.02.2020 1 Acta Neuropathol 1 Alzheimer Dis Assoc Disord 1 Ann Intern Med 1 BMC Geriatr 2 BMC Neurosci 1 Dement Geriatr Cogn Disord 8 J Alzheimers Dis 1 J Neurosci 2 Lancet Neurol 1 Nat Neurosci 6 Nat Rev Neurol 5 Neurobiol Aging 1 Neurobiol Dis 1 Neurochem Res 2 Neurology 3 Neuropsychology 1 Neuroscience 1 PLoS Med 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neuropathol

1. EVANS CE, Miners JS, Piva G, Willis CL, et al
   ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
   Acta Neuropathol. 2020 Jan 25. pii: 10.1007/s00401-019-02098.
   PubMed     Text format     Abstract available
   
   

   
   Alzheimer Dis Assoc Disord

2. SHERZAI AZ, Parasram M, Haider JM, Sherzai D, et al
   Alzheimer Disease and Cancer: A National Inpatient Sample Analysis.
   Alzheimer Dis Assoc Disord. 2020 Jan 27. doi: 10.1097/WAD.0000000000000369.
   PubMed     Text format     Abstract available
   
   

   
   Ann Intern Med

3. KARLAWISH J
   Social Cognition and the Aging Brain.
   Ann Intern Med. 2019;170:726-727.
   PubMed     Text format    
   
   

   
   BMC Geriatr

4. PIMOUGUET C, Sitta R, Wittwer J, Hayes N, et al
   Maintenance of occupational therapy (OT) for dementia: protocol of a multi-center, randomized controlled and pragmatic trial.
   BMC Geriatr. 2019;19:35.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurosci

5. NIMMY JOHN T, Subha Dharmapalan P, Ramshekhar Menon N
   Exploration of time-frequency reassignment and homologous inter-hemispheric asymmetry analysis of MCI-AD brain activity.
   BMC Neurosci. 2019;20:38.
   PubMed     Text format     Abstract available
   
   
6. PANTHER P, Kuehne M, Voges J, Nullmeier S, et al
   Electric stimulation of the medial forebrain bundle influences sensorimotor gaiting in humans.
   BMC Neurosci. 2019;20:20.
   PubMed     Text format     Abstract available
   
   

   
   Dement Geriatr Cogn Disord

7. CHEN TB, Lai YH, Ke TL, Chen JP, et al
   Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
   Dement Geriatr Cogn Disord. 2020 Jan 28:1-16. doi: 10.1159/000505435.
   PubMed     Text format     Abstract available
   
   

   
   J Alzheimers Dis

8. JIA J, Wei C, Chen W, Jia L, et al
   Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.
   J Alzheimers Dis. 2020 Jan 21. pii: JAD190940. doi: 10.3233/JAD-190940.
   PubMed     Text format     Abstract available
   
   
9. MENDES FR, Leclerc JL, Liu L, Kamat PK, et al
   Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models.
   J Alzheimers Dis. 2020 Jan 24. pii: JAD191069. doi: 10.3233/JAD-191069.
   PubMed     Text format     Abstract available
   
   
10. MALEK-AHMADI M, Perez SE, Chen K, Mufson EJ, et al
    Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 24. pii: JAD191151. doi: 10.3233/JAD-191151.
    PubMed     Text format     Abstract available
    
    
11. WESTWOOD S, Baird AL, Anand SN, Nevado-Holgado AJ, et al
    Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
    J Alzheimers Dis. 2020 Jan 22. pii: JAD190434. doi: 10.3233/JAD-190434.
    PubMed     Text format     Abstract available
    
    
12. EZZATI A, Lipton RB
    Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190822. doi: 10.3233/JAD-190822.
    PubMed     Text format     Abstract available
    
    
13. BEYER L, Brendel M, Scheiwein F, Sauerbeck J, et al
    Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-beta Positron Emission Tomography.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190818. doi: 10.3233/JAD-190818.
    PubMed     Text format     Abstract available
    
    
14. DOREY JM, Rouch I, Padovan C, Boublay N, et al
    Neuroticism-Withdrawal and Neuroticism-Volatility Differently Influence the Risk of Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190884. doi: 10.3233/JAD-190884.
    PubMed     Text format     Abstract available
    
    
15. NAKANISHI M, Igarashi A, Ueda K, Brnabic AJM, et al
    Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
    J Alzheimers Dis. 2020 Jan 19. pii: JAD190811. doi: 10.3233/JAD-190811.
    PubMed     Text format     Abstract available
    
    

    
    J Neurosci

16. MEILANDT WJ, Ngu H, Gogineni A, Lalehzadeh G, et al
    Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Abeta42:Abeta40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer's mouse model.
    J Neurosci. 2020 Jan 24. pii: JNEUROSCI.1871-19.2019.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Neurol

17. ANDREWS SJ, Fulton-Howard B, Goate A
    Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.
    Lancet Neurol. 2020 Jan 24. pii: S1474-4422(19)30435.
    PubMed     Text format     Abstract available
    
    
18. SCHNEIDER L
    A resurrection of aducanumab for Alzheimer's disease.
    Lancet Neurol. 2020;19:111-112.
    PubMed     Text format    
    
    

    
    Nat Neurosci

19. MANCUSO R, Van Den Daele J, Fattorelli N, Wolfs L, et al
    Stem-cell-derived human microglia transplanted in mouse brain to study human disease.
    Nat Neurosci. 2019;22:2111-2116.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Neurol

20. MATTSSON N, Hansson O
    Primary fatty amides are potential plasma biomarkers for AD.
    Nat Rev Neurol. 2019;15:498-499.
    PubMed     Text format    
    
    
21. LEMPRIERE S
    T cells on patrol in Alzheimer disease.
    Nat Rev Neurol. 2020 Jan 27. pii: 10.1038/s41582-020-0317.
    PubMed     Text format    
    
    
22. FYFE I
    Alzheimer disease-associated gene increases tau pathology.
    Nat Rev Neurol. 2020 Jan 30. pii: 10.1038/s41582-020-0318.
    PubMed     Text format    
    
    
23. WOOD H
    AAIC 2019 highlights sex differences in AD.
    Nat Rev Neurol. 2019;15:494.
    PubMed     Text format    
    
    
24. WOOD H
    AD biomarkers at AAIC 2019.
    Nat Rev Neurol. 2019;15:494.
    PubMed     Text format    
    
    
25. KNOPMAN DS
    Bad news and good news in AD, and how to reconcile them.
    Nat Rev Neurol. 2019;15:61-62.
    PubMed     Text format    
    
    

    
    Neurobiol Aging

26. SLOT RER, Kester MI, Van Harten AC, Jongbloed W, et al
    ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Abeta42, levels in non-demented elderly.
    Neurobiol Aging. 2019;79:101-109.
    PubMed     Text format     Abstract available
    
    
27. LEE YH, Bak Y, Park CH, Chung SJ, et al
    Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia.
    Neurobiol Aging. 2019 Dec 30. pii: S0197-4580(19)30450.
    PubMed     Text format     Abstract available
    
    
28. MCKENZIE C, Bucks RS, Weinborn M, Bourgeat P, et al
    Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology.
    Neurobiol Aging. 2020 Jan 3. pii: S0197-4580(19)30451.
    PubMed     Text format     Abstract available
    
    
29. BATZU L, Westman E, Pereira JB
    Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.
    Neurobiol Aging. 2019 Dec 20. pii: S0197-4580(19)30440.
    PubMed     Text format     Abstract available
    
    
30. FRANZ CE, Xian H, Lew D, Hatton SN, et al
    Body mass trajectories and cortical thickness in middle-aged men: a 42-year longitudinal study starting in young adulthood.
    Neurobiol Aging. 2019;79:11-21.
    PubMed     Text format     Abstract available
    
    

    
    Neurobiol Dis

31. TRAMUTOLA A, Lanzillotta C, Di Domenico F, Head E, et al
    Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome.
    Neurobiol Dis. 2020 Jan 24:104772. doi: 10.1016/j.nbd.2020.104772.
    PubMed     Text format     Abstract available
    
    

    
    Neurochem Res

32. KRISTOFIKOVA Z, Springer T, Gedeonova E, Hofmannova A, et al
    Interactions of 17beta-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease.
    Neurochem Res. 2020 Jan 29. pii: 10.1007/s11064-020-02970.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

33. HOLLAND TM, Agarwal P, Wang Y, Leurgans SE, et al
    Dietary flavonols and risk of Alzheimer dementia.
    Neurology. 2020 Jan 29. pii: WNL.0000000000008981.
    PubMed     Text format     Abstract available
    
    
34. RESENDE EPF, Nolan AL, Petersen C, Ehrenberg AJ, et al
    Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes: Astrocytic tau, cognitive function, and Alzheimer disease.
    Neurology. 2020 Jan 30. pii: WNL.0000000000008937.
    PubMed     Text format     Abstract available
    
    

    
    Neuropsychology

35. REEVES S, Williams V, Costela FM, Palumbo R, et al
    Narrative video scene description task discriminates between levels of cognitive impairment in Alzheimer's disease.
    Neuropsychology. 2020 Jan 30. pii: 2020-05494-001. doi: 10.1037/neu0000621.
    PubMed     Text format     Abstract available
    
    
36. WEITZNER DS, Calamia M
    Serial position effects on list learning tasks in mild cognitive impairment and Alzheimer's disease.
    Neuropsychology. 2020 Jan 30. pii: 2020-05742-001. doi: 10.1037/neu0000620.
    PubMed     Text format     Abstract available
    
    
37. GUAZZO F, Allen RJ, Baddeley AD, Della Sala S, et al
    Unimodal and crossmodal working memory binding is not differentially affected by age or Alzheimer's disease.
    Neuropsychology. 2020 Jan 30. pii: 2020-05743-001. doi: 10.1037/neu0000622.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

38. PAOLICELLI RC, Bergamini G, Rajendran L
    Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia.
    Neuroscience. 2019;405:148-157.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

39. MAHAJAN UV, Varma VR, Griswold ME, Blackshear CT, et al
    Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    PLoS Med. 2020;17:e1003012.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

40. LIAO JY, Lee CT, Lin TY, Liu CM, et al
    Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia.
    PLoS One. 2020;15:e0228172.
    PubMed     Text format     Abstract available
    
    
41. SUN YQ, Richmond RC, Chen Y, Mai XM, et al
    Mixed evidence for the relationship between periodontitis and Alzheimer's disease: A bidirectional Mendelian randomization study.
    PLoS One. 2020;15:e0228206.
    PubMed     Text format     Abstract available
    
    
42. LEE EG, Tulloch J, Chen S, Leong L, et al
    Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.
    PLoS One. 2020;15:e0227667.
    PubMed     Text format     Abstract available
    
    
43. ESQUERDA-CANALS G, Marti-Clua J, Villegas S
    Pharmacokinetic parameters and mechanism of action of an efficient anti-Abeta single chain antibody fragment.
    PLoS One. 2019;14:e0217793.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: